Research Associate in Genetic Vector Control

Company: Imperial College London
Apply for the Research Associate in Genetic Vector Control
Location: London
Job Description:

Overview

In this role you contribute to a Gates Foundation–funded program developing self-limiting genetic strategies to suppress Anopheles populations. You will work within a small, collaborative team to advance proof-of-principle technologies toward potential deployment, while exploring new target genes and molecular tools. You’ll design and execute experiments, analyze robust data, and contribute to publications and funder meetings. You will engage with internal and external collaborators and support student development, fostering a safe, productive lab environment. This is a chance to impact malaria control through cutting-edge molecular biology.

Pay / Benefits

  • Development days (10 per year)
  • 43 days off per year
  • generous pension schemes
  • competitive benefits package
  • career development support
  • inclusive working environment

Responsibilities

  • Plan and deliver research within the programme
  • Design and perform experiments with molecular approaches
  • Analyze robust and reproducible data and maintain accurate records
  • Contribute to publications, presentations, and funder meetings
  • Collaborate with Imperial scientists and external partners
  • Supervise and develop students and research assistants
  • Coordinate small research team activities and help run the lab
  • Maintain a safe, collaborative laboratory environment

Key requirements

  • Experience in molecular biology and genetic engineering including DNA cloning and CRISPR-Cas9 or related genome-editing approaches
  • Experience with mosquitoes or other model organisms
  • Transcriptomic data analysis experience
  • Molecular and genetic assays experience
  • Basic experience in bioinformatics and data analysis
  • Embryo microinjection experience preferred
  • Proactive and motivated researcher
  • Strong collaboration and teamwork
  • Effective communication for publications and meetings
  • DNA cloning
  • Genetic construct design
  • CRISPR-Cas9 or genome-editing methods

…

Posted: October 16th, 2026